An organized set of primary and secondary sources covering clinical background, drug-safety signals, and patient-safety considerations.
Avelumab Merkel Cell Carcinoma lawsuit eligibility overview — detailed background and analysis.
Reference: European Medicines Agency (EMA)
Authoritative source for clinical, regulatory, and public-health background reading.
Reference: Wikipedia: Medical Malpractice
Authoritative source for clinical, regulatory, and public-health background reading.
Reference: Mayo Clinic — Diseases & Conditions
Authoritative source for clinical, regulatory, and public-health background reading.